Altimmune Statement on the Passing of Dr. Stephen Harrison
26 4월 2024 - 6:24AM
The Altimmune team would like to express our sorrow and extend our
heartfelt condolences to Dr. Stephen Harrison’s family following
his tragic and unexpected passing.
Dr. Harrison’s countless contributions to advancing needed
treatments for metabolic liver disease will leave a profound and
lasting legacy throughout our field, with his patients and the
people engaged in understanding and treating liver disease. His
brilliance and vision were only rivaled by his eloquence, charisma
and steadfast commitment to improving the lives of people with
liver disease. He was a tireless advocate for patients and a deeply
respected advisor, investigator and friend to Altimmune.
We will miss him greatly as we adjust to this tremendous loss
for the community. We honor his memory and are grateful for having
known and worked with him.
Contact:Rich EisenstadtChief Financial
OfficerPhone: 240-654-1450reisenstadt@altimmune.com
Altimmune (NASDAQ:ALT)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Altimmune (NASDAQ:ALT)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024